"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
Descriptor ID |
D001932
|
MeSH Number(s) |
C04.588.614.250.195 C10.228.140.211 C10.551.240.250
|
Concept/Terms |
Brain Neoplasms- Brain Neoplasms
- Neoplasms, Brain
- Brain Neoplasm
- Neoplasm, Brain
- Brain Tumors
- Brain Tumor
- Tumor, Brain
- Tumors, Brain
Brain Cancer- Brain Cancer
- Brain Cancers
- Cancer, Brain
- Cancers, Brain
- Malignant Neoplasms, Brain
- Brain Malignant Neoplasm
- Brain Malignant Neoplasms
- Malignant Neoplasm, Brain
- Cancer of Brain
- Cancer of the Brain
- Neoplasms, Brain, Malignant
- Brain Neoplasms, Malignant
- Brain Neoplasm, Malignant
- Malignant Brain Neoplasm
- Malignant Brain Neoplasms
Brain Tumor, Recurrent- Brain Tumor, Recurrent
- Brain Tumors, Recurrent
- Recurrent Brain Tumor
- Recurrent Brain Tumors
Malignant Primary Brain Tumors- Malignant Primary Brain Tumors
- Primary Malignant Brain Tumors
- Malignant Primary Brain Neoplasms
- Primary Malignant Brain Neoplasms
- Brain Neoplasms, Malignant, Primary
- Brain Neoplasms, Primary Malignant
Benign Neoplasms, Brain- Benign Neoplasms, Brain
- Benign Neoplasm, Brain
- Brain Benign Neoplasm
- Brain Benign Neoplasms
- Neoplasms, Brain, Benign
- Brain Neoplasms, Benign
- Benign Brain Neoplasm
- Benign Brain Neoplasms
- Brain Neoplasm, Benign
Brain Tumor, Primary- Brain Tumor, Primary
- Brain Tumors, Primary
- Primary Brain Tumor
- Primary Brain Tumors
- Neoplasms, Brain, Primary
- Brain Neoplasm, Primary
- Brain Neoplasms, Primary
- Primary Brain Neoplasm
- Primary Brain Neoplasms
|
Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".
This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 30 | 3 | 33 |
1995 | 28 | 4 | 32 |
1996 | 31 | 6 | 37 |
1997 | 27 | 5 | 32 |
1998 | 24 | 1 | 25 |
1999 | 25 | 7 | 32 |
2000 | 29 | 8 | 37 |
2001 | 25 | 2 | 27 |
2002 | 38 | 2 | 40 |
2003 | 43 | 16 | 59 |
2004 | 58 | 9 | 67 |
2005 | 41 | 6 | 47 |
2006 | 45 | 7 | 52 |
2007 | 72 | 11 | 83 |
2008 | 77 | 12 | 89 |
2009 | 66 | 6 | 72 |
2010 | 102 | 14 | 116 |
2011 | 84 | 11 | 95 |
2012 | 92 | 15 | 107 |
2013 | 106 | 11 | 117 |
2014 | 103 | 15 | 118 |
2015 | 108 | 14 | 122 |
2016 | 92 | 10 | 102 |
2017 | 117 | 7 | 124 |
2018 | 101 | 13 | 114 |
2019 | 109 | 12 | 121 |
2020 | 104 | 9 | 113 |
2021 | 116 | 5 | 121 |
2022 | 85 | 5 | 90 |
2023 | 90 | 0 | 90 |
2024 | 17 | 0 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.
-
Understanding the mechanisms of diffuse midline glioma cell migration toward therapeutic targeting. Neuro Oncol. 2024 03 04; 26(3):569-570.
-
Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy. Proc Natl Acad Sci U S A. 2024 Feb 20; 121(8):e2306973121.
-
Recommended Resting-State fMRI Acquisition and Preprocessing Steps for Preoperative Mapping of Language and Motor and Visual Areas in Adult and Pediatric Patients with Brain Tumors and Epilepsy. AJNR Am J Neuroradiol. 2024 Feb 07; 45(2):139-148.
-
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice. Mol Ther. 2024 Mar 06; 32(3):722-733.
-
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma. Neuro Oncol. 2024 02 02; 26(2):236-250.
-
The effects of oxaliplatin-based?adjuvant?chemotherapy?in?high-risk?stage?II?colon?cancer with mismatch repair-deficient: a retrospective study. BMC Cancer. 2024 Feb 02; 24(1):164.
-
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas. Nat Commun. 2024 Jan 25; 15(1):730.
-
Impact of tissue-agnostic approvals on management of primary brain tumors. Trends Cancer. 2024 Mar; 10(3):256-274.
-
The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathol Commun. 2024 Jan 19; 12(1):13.
-
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell. 2024 01 18; 187(2):446-463.e16.